Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
S Ugurlu, B Ergezen, BH Egeli, O Selvi… - Rheumatology, 2021 - academic.oup.com
Objectives Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
S Ugurlu, B Ergezen, BH Egeli, O Selvi… - …, 2021 - search.ebscohost.com
Objectives Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
S UĞURLU, B Ergezen, B Egeli, O Selvi… - …, 2021 - avesis.istanbul.edu.tr
Objectives. Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
S Ugurlu, B Ergezen, BH Egeli… - Rheumatology …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
S Ugurlu, B Ergezen, BH Egeli, O Selvi… - Rheumatology (Oxford …, 2021 - europepmc.org
Objectives Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience
S Ugurlu, B Ergezen, BH Egeli, O Selvi… - Rheumatology, 2021 - academic.oup.com
Objectives Anakinra is proven to be effective in controlled trials in terms of attack frequency
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …
and subclinical inflammation in colchicine-resistant patients. The objective of this study was …